Literature DB >> 3772295

Subcellular location and properties of bactericidal factors from human neutrophils.

J E Gabay, J M Heiple, Z A Cohn, C F Nathan.   

Abstract

We examined the subcellular location of bactericidal factors (BF) in human neutrophils, using an efficient fractionation scheme. Nitrogen bomb cavitates of DIFP-treated PMN were centrifuged through discontinuous Percoll gradients, each fraction extracted with 0.05 M glycine, pH 2.0, and tested for the killing of Escherichia coli. greater than 90% of BF coisolated with the azurophil granules. After lysis of azurophils, 98% of azurophil-derived BF (ADBF) sedimented with the membrane. ADBF activity was solubilized from azurophil membrane with either acid or nonionic detergent (Triton X-100, Triton X-114). Bactericidal activity was linear with respect to protein concentration over the range 0.3-30 micrograms/ml. 0.1-0.3 microgram/ml ADBF killed 10(5) E. coli within 30 min at 37 degrees C. At 1.4 micrograms/ml, 50% of 2 X 10(5) bacteria were killed within 5 min. ADBF was effective between pH 5-8, with peak activity at pH 5.5. Glucose (20 mM), EDTA (1-25 mM), and physiologic concentrations of NaCl or KCl had little or no inhibitory effect on ADBF. ADBF killed both Gram-positive and Gram-negative virulent clinical isolates, including listeria, staphylococci, beta-hemolytic streptococci, and Pseudomonas aeruginosa. Thus, under these conditions of cell disruption, fractionation, extraction, and assay, almost all BF in human PMN appeared to be localized to the membrane of azurophilic granules as a highly potent, broad-spectrum, rapidly acting protein(s) effective in physiologic medium. Some of these properties appear to distinguish ADBF from previously described PMN bactericidal proteins.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3772295      PMCID: PMC2188462          DOI: 10.1084/jem.164.5.1407

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  32 in total

Review 1.  Molecular basis of bacterial outer membrane permeability.

Authors:  H Nikaido; M Vaara
Journal:  Microbiol Rev       Date:  1985-03

Review 2.  Endocytosis.

Authors:  S C Silverstein; R M Steinman; Z A Cohn
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

3.  Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes.

Authors:  J Weiss; P Elsbach; I Olsson; H Odeberg
Journal:  J Biol Chem       Date:  1978-04-25       Impact factor: 5.157

4.  Bactericidal activity of aerobic and anaerobic polymorphonuclear neutrophils.

Authors:  G L Mandell
Journal:  Infect Immun       Date:  1974-02       Impact factor: 3.441

5.  Studies of polymorphonuclear leukocytes from patients with chronic granulomatous disease of childhood: bactericidal capacity for streptococci.

Authors:  E L Kaplan; T Laxdal; P G Quie
Journal:  Pediatrics       Date:  1968-03       Impact factor: 7.124

6.  Phase separation of integral membrane proteins in Triton X-114 solution.

Authors:  C Bordier
Journal:  J Biol Chem       Date:  1981-02-25       Impact factor: 5.157

7.  Purification and antibacterial activity of antimicrobial peptides of rabbit granulocytes.

Authors:  M E Selsted; D Szklarek; R I Lehrer
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

8.  Defensins. Natural peptide antibiotics of human neutrophils.

Authors:  T Ganz; M E Selsted; D Szklarek; S S Harwig; K Daher; D F Bainton; R I Lehrer
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

9.  Further studies on preparation and properties of phagocytin.

Authors:  J G HIRSCH
Journal:  J Exp Med       Date:  1960-03-01       Impact factor: 14.307

10.  Phagocytin: a bactericidal substance from polymorphonuclear leucocytes.

Authors:  J G HIRSCH
Journal:  J Exp Med       Date:  1956-05-01       Impact factor: 14.307

View more
  12 in total

1.  Epithelia: not just physical barriers.

Authors:  Tomas Ganz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

Review 2.  The early and late processing of lysosomal enzymes: proteolysis and compartmentation.

Authors:  A Hasilik
Journal:  Experientia       Date:  1992-02-15

3.  Azurocidin and a homologous serine protease from neutrophils. Differential antimicrobial and proteolytic properties.

Authors:  D Campanelli; P A Detmers; C F Nathan; J E Gabay
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

4.  Antibiotic proteins of human polymorphonuclear leukocytes.

Authors:  J E Gabay; R W Scott; D Campanelli; J Griffith; C Wilde; M N Marra; M Seeger; C F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

Review 5.  Cutaneous defenses against dermatophytes and yeasts.

Authors:  D K Wagner; P G Sohnle
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

6.  Human neutrophil-mediated fungistasis against Histoplasma capsulatum. Localization of fungistatic activity to the azurophil granules.

Authors:  S L Newman; L Gootee; J E Gabay
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

7.  Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages.

Authors:  D L Granger; J B Hibbs; J R Perfect; D T Durack
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

8.  In vivo administration of recombinant growth hormone or gamma interferon activities macrophages: enhanced resistance to experimental Salmonella typhimurium infection is correlated with generation of reactive oxygen intermediates.

Authors:  C K Edwards; S M Ghiasuddin; L M Yunger; R M Lorence; S Arkins; R Dantzer; K W Kelley
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

9.  Diversity of PR3-ANCA epitope specificity in Wegener's granulomatosis. Analysis using the biosensor technology.

Authors:  Agnieszka A Rarok; Ymke M van der Geld; Coen A Stegeman; Pieter C Limburg; Cees G M Kallenberg
Journal:  J Clin Immunol       Date:  2003-11       Impact factor: 8.317

10.  Isolation of a complementary DNA clone encoding a precursor to human eosinophil major basic protein.

Authors:  M McGrogan; C Simonsen; R Scott; J Griffith; N Ellis; J Kennedy; D Campanelli; C Nathan; J Gabay
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.